Medical Condition News

RSS

Amgen receives EC approval to extend therapeutic indications for Vectibix

Amgen today announced that the European Commission (EC) has approved a variation to the marketing authorization for Vectibix (panitumumab) to include indications for the treatment of patients with wild-type KRAS metastatic colorectal cancer (mCRC) in first-line in combination with FOLFOX and in second-line in combination with FOLFIRI in patients who have received first-line fluoropyrimidine-based chemotherapy.

16 Nov 2011

International Diabetes Federation report estimates 1 in 10 adults will have diabetes by 2030

"One in 10 adults will have diabetes by 2030, posing a huge challenge to health care systems around the world, according to a report" released by the International Diabetes Federation to coincide with World Diabetes Day on Monday, Reuters reports.

16 Nov 2011

Rosuvastatin as effective as atorvastatin in reversing atherosclerosis

Maximum doses of Crestor- (rosuvastatin) or Lipitor- (atorvastatin) are similarly effective in reversing the buildup of cholesterol plaques in the coronary artery walls (atherosclerosis) after 24 months of treatment, according to Cleveland Clinic researchers.

16 Nov 2011

Advaxis licenses ISG15 tumor antigen from University of Pennsylvania

Advaxis, Inc., a leader in developing the next generation of immunotherapies for cancer and infectious diseases, has exclusively licensed the use of antigen ISG15 in Advaxis' Lm-LLO based immunotherapies from the University of Pennsylvania.

16 Nov 2011

Study: Pneumonia the most common serious infection post-heart surgery

Pneumonia - not a deep incision surgical site infection - is the most common serious infection after heart surgery, according to new research presented at the American Heart Association's Scientific Sessions 2011.

16 Nov 2011

Researchers to begin drug development projects for rare and neglected diseases

Researchers will begin drug development projects for rare and neglected diseases that include potential treatments for a musculoskeletal disorder, a cognitive dysfunction disorder, a virus that affects the central nervous system of newborns, a parasitic worm infection, a form of muscular dystrophy and a rare lung disease.

16 Nov 2011

Niacin not effective in reducing risk of stroke, heart attack in stable CV patients

In patients whose bad cholesterol is very well-controlled by statins for a long time period, the addition of high-dose, extended release niacin did not reduce the risk of cardiovascular events, including heart attack and stroke.

16 Nov 2011

New research identifies brain chemicals and circuits involved in mental illnesses

New research identifies the brain chemicals and circuits involved in mental illnesses like schizophrenia, depression, and anxiety, giving potential new directions to their treatment.

16 Nov 2011

Study examines changes in siblings after death of a brother or sister from cancer

The majority of children experience personal changes and changes in relationships one year after their sibling has died from cancer; however, positive and negative changes are not universal. These are the findings from the first study - published online November 3, 2011 in Cancer Nursing - to examine changes in siblings after the death of a brother or sister to cancer from three different perspectives: mothers, fathers and siblings.

16 Nov 2011

Scientists discover gene that helps protect body from squamous cell cancer

An extraordinary breakthrough in understanding what stops a common form of skin cancer from developing could make new cancer treatments and prevention available to the public in five years.

16 Nov 2011

Research offers clues that may explain behavior, mood changes in stress-related disorders

Research released today uses the latest genetic tools to explore how stress alters brain function, leading to anxiety, depression, and other stress-related mood disorders.

16 Nov 2011

New method to stack synthetic DNA and carbon nanotubes onto biosensor electrode

Purdue University scientists have developed a method for stacking synthetic DNA and carbon nanotubes onto a biosensor electrode, a development that may lead to more accurate measurements for research related to diabetes and other diseases.

16 Nov 2011

Self-directed rehabilitation improves outcomes for stroke patients

Community rehabilitation interventions for stroke patients have not had a great track record of delivering measurable improvements. But new research from New Zealand focused on Maori and Pacific populations shows how a cheap and simple intervention that puts the patient and families in charge can make a difference to their quality of life. The study can be found in the journal Clinical Rehabilitation, which is published by SAGE.

16 Nov 2011

Combination of antipsychotic and antidepressant drugs may increase risk of CV mortality

People taking anti-psychotic drugs and anti-depressant drugs have a much higher risk of dying during an acute coronary event of a fatal arrhythmia than the rest of the population, finds a Finnish study published in the European Heart Journal.

16 Nov 2011

New paper shows how platelets help promote cancer metastasis

About 90 percent of cancer deaths are caused by secondary tumors, known as metastases, which spread from the original tumor site. To become mobile and break free from the original tumor, cancer cells need help from other cells in their environment. Many cells have been implicated in this process, including immune system cells and cells that form connective tissue. Another collaborator in metastasis is platelets, the blood cells whose normal function is to promote blood clotting.

16 Nov 2011

International consortium develops first-in-class adiponectin receptor agonist

A compound that mimics the effects of adiponectin, a beneficial protein that is produced by fat tissue in healthy weight individuals and may exhibit protective effects against cancer, cardiovascular disease, inflammatory conditions and insulin resistance has been developed by an international consortium lead by Dr. Eva Surmacz, Associate Professor in Biology (Adjunct) and director of the Obesity and Cancer Program at the Sbarro Institute for Cancer Research and Molecular Medicine at Temple University's College of Science and Technology.

16 Nov 2011

New health institute to combat chronic diseases across Maryland

Jay A. Perman, MD, President of the University of Maryland, and Joshua M. Sharfstein, MD, Secretary of the Maryland Department of Health and Mental Hygiene (DHMH), announced today the creation of the Institute for a Healthiest Maryland, a collaboration of support systems that will guide efforts to combat chronic diseases across Maryland.

16 Nov 2011

Evacetrapib drug may increase HDL-C and decrease LDL-C levels

Among patients with sub-optimal low-density lipoprotein cholesterol (LDL-C) or high-density lipoprotein cholesterol (HDL-C) levels, use of the drug evacetrapib alone or in combination with statin medications was associated with significant increases in HDL-C levels and decreases in LDL-C levels, according to a study appearing in the November 16 issue of JAMA, a theme issue on cardiovascular disease.

16 Nov 2011

EMA grants orphan designation to AMT for hemophilia B gene therapy

Amsterdam Molecular Therapeutics, a leader in the field of human gene therapy, announced today that the European Medicines Agency (EMA) has granted orphan designation for its gene therapy program for the treatment of hemophilia B. Orphan designation in the European Union provides several benefits including 10 years of market exclusivity from product launch and access to the central authorization procedure.

16 Nov 2011

Researchers identify key processes by which estrogen activates genes in breast-cancer cells

Researchers at the Keck School of Medicine of the University of Southern California (USC) have discovered key processes by which estrogen, the female sex hormone, activates genes in breast-cancer cells.

16 Nov 2011

Medical Condition News

Amgen receives EC approval to extend therapeutic indications for Vectibix

International Diabetes Federation report estimates 1 in 10 adults will have diabetes by 2030

Rosuvastatin as effective as atorvastatin in reversing atherosclerosis

Advaxis licenses ISG15 tumor antigen from University of Pennsylvania

Study: Pneumonia the most common serious infection post-heart surgery

Researchers to begin drug development projects for rare and neglected diseases

Niacin not effective in reducing risk of stroke, heart attack in stable CV patients

New research identifies brain chemicals and circuits involved in mental illnesses

Study examines changes in siblings after death of a brother or sister from cancer

Scientists discover gene that helps protect body from squamous cell cancer

Research offers clues that may explain behavior, mood changes in stress-related disorders

New method to stack synthetic DNA and carbon nanotubes onto biosensor electrode

Self-directed rehabilitation improves outcomes for stroke patients

Combination of antipsychotic and antidepressant drugs may increase risk of CV mortality

New paper shows how platelets help promote cancer metastasis

International consortium develops first-in-class adiponectin receptor agonist

New health institute to combat chronic diseases across Maryland

Evacetrapib drug may increase HDL-C and decrease LDL-C levels

EMA grants orphan designation to AMT for hemophilia B gene therapy

Researchers identify key processes by which estrogen activates genes in breast-cancer cells

Bioprocess Efficiency with Cell Density Monitoring

Exploring electron microscopy for plant and microbial imaging at the John Innes Centre

Extending the reach of Amperia™

Latest News